Abstract: Tumor angiogenesis is critical for tumor growth, invasion and metastasis. It occurs as a result of an imbalance between angiogenic cytokines and angiogenesis inhibitors. Targeting tumor angiogenesis is an important strategy in tumor treatment. Gene therapies deliver targeted anti-angiogenesis therapy. In this article, we review the current research on tumor angiogenesis and anti-angiogenesis gene therapy.